(Q52533955)

English

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies.

scientific article published in March 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

title

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

1 reference

Griffin SV

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

Chapman PT

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

Lianos EA

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

Lockwood CM

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

language of work or name

English

0 references

publication date

1 March 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

published in

Kidney International

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

volume

55

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

page(s)

917-925

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

exact match

https://scigraph.springernature.com/pub.10.1046/j.1523-1755.1999.055003917.x

0 references

Identifiers

DOI

10.1046/J.1523-1755.1999.055003917.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

Dimensions Publication ID

1024877811

0 references

PubMed publication ID

10027928

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10027928

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/10027928

ResearchGate publication ID

13261512

0 references

(Q52533955)

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)